RYOIX
Rydex Biotechnology Inv
1W: -2.3%
1M: -4.2%
3M: +1.2%
YTD: +24.0%
1Y: +24.4%
3Y: +40.6%
5Y: +8.6%
$93.21
+0.07 (+0.08%)
Weekly Expected Move ±2.6%
$88
$91
$93
$96
$98
Portfolio Health Summary
IS Overall Score
53.1
★★★★★
Altman Z-Score
11.38
Safe
Weight Coverage
92%
of portfolio analyzed
Holdings Matched
69
with fundamental data
InsiderStreet Scorecard
★★★★★
53.1
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
11.38
Safe Zone (>2.99)
Piotroski F-Score
5.0 / 9
Moderate
Beneish M-Score
-0.11
Possible Manipulator
Credit Score
—
Earnings Quality
52.9 / 100
Portfolio Valuation
P/E
38.88x
P/B
8.41x
P/S
5.22x
EV/EBITDA
21.63x
EV/Revenue
8.01x
P/FCF
19.40x
P/OCF
17.61x
PEG
3.38x
Earnings Yield
2.57%
FCF Yield
5.15%
OCF Yield
5.68%
Median P/E
-6.48x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+31.3%
Net Income
+26.9%
EPS
+30.7%
FCF
+25.4%
EBITDA
+33.5%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+40.6%
Rev CAGR 5Y
+32.2%
EPS CAGR 3Y
+11.5%
EPS CAGR 5Y
+10.6%
FCF CAGR 3Y
+8.0%
FCF CAGR 5Y
+18.9%
EBITDA CAGR 3Y
+9.9%
EBITDA CAGR 5Y
+8.7%
Payout Ratio
33.48%
Buyback Yield
1.32%
Dividend Yield
0.49%
Total Shareholder Return
-1.57%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$93.14
Median 1Y
$96.76
5th Pctile
$62.87
95th Pctile
$148.87
Ann. Volatility
25.7%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 38.88 |
| Portfolio P/B | 8.41 |
| Portfolio P/S | 5.22 |
| EV/EBITDA | 21.63 |
| EV/Revenue | 8.01 |
| P/FCF | 19.40 |
| P/OCF | 17.61 |
| PEG | 3.38 |
| Earnings Yield | 2.57% |
| FCF Yield | 5.15% |
| OCF Yield | 5.68% |
| Median P/E | -6.48 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 81.99% |
| Operating Margin | 27.43% |
| Net Margin | 6.20% |
| FCF Margin | 25.10% |
| ROE | 10.44% |
| ROA | 2.72% |
| ROIC | 17.26% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 1.49 |
| Debt/Assets | 0.40 |
| Net Debt/EBITDA | 1.72 |
| Interest Coverage | 7.16 |
| Current Ratio | 1.28 |
| Quick Ratio | 1.07 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 31.34% |
| Net Income Growth | 26.94% |
| EPS Growth | 30.72% |
| FCF Growth | 25.39% |
| EBITDA Growth | 33.49% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 40.63% |
| Revenue CAGR 5Y | 32.18% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 11.51% |
| EPS CAGR 5Y | 10.59% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | 8.02% |
| FCF CAGR 5Y | 18.93% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | 9.94% |
| EBITDA CAGR 5Y | 8.70% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | 9.87% |
| Net Income CAGR 5Y | 10.16% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 53.1 |
| IS Profitability | 51.9 |
| IS Balance Sheet | 55.7 |
| IS Earnings Quality | 52.9 |
| IS Growth | 60.0 |
| IS Value | 39.7 |
| IS Momentum | 70.4 |
| IS Safety | 81.2 |
| IS Quality | 60.9 |
| Altman Z-Score | 11.38 |
| Piotroski F-Score | 4.98 |
| Beneish M-Score | -0.11 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.49% |
| Payout Ratio | 33.48% |
| Buyback Yield | 1.32% |
| Total Shareholder Return | -1.57% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.770 |
| Earnings Stability | 0.479 |
| Earnings Persistence | 0.638 |
| Margin Stability | 0.769 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -6.48 |
| Median P/B | 5.57 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 92.41% |
| Holdings Matched | 69 |
| Total Holdings | 70 |